CA
NZ
UK
AU
IND
US
Exelixis, Inc. (NASDAQ:EXEL) shares were trading near their 52-week high at USD 64.47 on October 21, 2026, up 0.12%. The oncology company reported second quarter results in a Form 10-Q filed August 5, announced a new $750 million buyback in May, and has an …
Fortrea (NASDAQ:FTRE) shares were trading near their 52-week high at USD 23.78 on October 21, 2026, up 4.39%. The contract research organization filed its second quarter 2026 report on July 29, which disclosed a July court action over its chief financial officer appointment and …
Halozyme Therapeutics (NASDAQ:HALO) shares were trading near their 52-week high at USD 124.11 on October 21, 2026, down 0.21%. The drug delivery company signed ENHANZE and Hypercon licensing agreements with GSK, Vertex, Oruka and Incyte between April and July, announced a $1.0 billion share …
Heartflow (NASDAQ:HTFL) shares were trading near their 52-week high at USD 55.94 on October 21, 2026, up 0.63%. The coronary artery disease software company launched its PCI Navigator product in April, sued a competitor over patents that month, and filed its quarterly report for …
Hinge Health (NYSE:HNGE) shares were trading near their 52-week high at USD 110.86 on October 21, 2026, up 3.12%. The digital care company filed its quarterly report for the period ended June 30, 2026 on August 6, after its board expanded the share repurchase …
InfuSystem Holdings (NYSE American:INFU) shares were trading near their 52-week high at USD 13.95 on October 21, 2026, down 1.97%. The infusion services provider approved a new repurchase program in May and filed its quarterly report for the period ended June 30, 2026 on …
Iovance Biotherapeutics (NASDAQ:IOVA) shares were trading near their 52-week high at USD 14.95 on October 21, 2026, up 0.57%. The cell therapy company won marketing authorization with conditions for its melanoma treatment Amtagvi in Australia on June 4, resubmitted its UK application in July, …
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) shares were trading near their 52-week high at USD 80.22 on October 21, 2026, down 3.55%. The cardiovascular-focused biopharmaceutical company started its pivotal Phase 3 trial of KPL-387 in July and filed its quarterly report for the period ended June …
Moderna, Inc. (NASDAQ:MRNA) shares were trading near their 52-week high at USD 249.76 on October 21, 2026, up 3.17%. The mRNA medicines company settled its Arbutus and Genevant patent litigation in March, won European authorization for its flu plus COVID vaccine in April, expanded …
National HealthCare (NYSE American:NHC) shares were trading near their 52-week high at USD 243.49 on October 21, 2026, down 1.79%. The senior health care operator acquired five skilled nursing facilities on June 1 and announced its second quarter 2026 earnings in an August 7 …
Please wait processing your request...